Lee et al., reported CX3CR1 deficiency reduced Aβ deposition and neuronal loss in APP-PS1 and R1.40 mouse models of AD, along with the reduction in microglia surrounding Aβ plaques, as demonstrated by immunohistochemical analysis using the CD68 microglial marker [40]. This evidence concerns the gene CX3CR1 and Alzheimer disease.